SLC12A5 and prostate carcinoma: To further validate these results, we subsequently analyzed the TCGA prostate cancer datasets and found that the expression of SLC12A5 mRNA in prostate tumor tissues was significantly higher than that in normal tissues (P < 0.01) (Fig. 1E).